← All claims

Metabolic & Cardiometabolic · Gut & Microbiome

microbial tryptophan metabolites increases enteroendocrine L-cell differentiation

In plain terms: Can gut-bacteria tryptophan compounds grow more of the cells that make the blood-sugar hormone GLP-1?

Leans support Metabolic & Cardiometabolic 🐭 Non-human evidence🔬 Includes disconfirming
RefutedContestedStrong support
consensus score 0.45

Yes, shown in human gut mini-organs and rodents, but more cells isn't a proven real-world effect.

📅 Last reviewed: 2026-07-15

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: Animal studies (Animal)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

4 support 1 contradict 3 tested null 1 mixed · 9 sources, 5 independent groups

What the evidence shows

Microbial tryptophan metabolites (indole) drive enteroendocrine-cell differentiation, countering the reduced GLP-1 capacity seen in obesity — shown in HUMAN colonic organoids plus rodent models. Differentiation != proven postprandial GLP-1 rise, but it is the best human-tissue support.

The evidence (9)

SourceGradeStanceQualityFinding
Buckley MM et al] # corrected 2026-08-17 from PubMed; was [(indole-vagal)
2020 · (rat)
animal tested-null low [FT-verified] Indole-vagal L-cell GLP-1 to rat vagal afferents (secretion/signalling not differentiation)
Chimerel C, et al.
2014 · Cell Rep
in-vitro tested-null moderate [FT-verified] Chimerel indole acutely up then chronically down GLP-1 (mouse L-cells; SECRETION not differentiation)
Li
2025 · Gut Microbes
animal supports moderate Pig model: time-restricted feeding raised serum/hypothalamic GLP-1 via gut microbial tryptophan metabolites - supports Trp-metabolite L-cell axis
Yin
2026 · J Anim Sci
animal contradicts moderate Dietary indole-3-acetate (microbial Trp metabolite) improved intestinal morphology and enteroendocrine/nutrient outcomes in vivo
Vanslette AM, et al.
2023 · Eur J Pharmacol
animal supports moderate [FT-verified] Vanslette 5-HT4 agonism raised colonic Gcg/GLP-1 HFD mice. ANIMAL
Phuah P, et al.
2026 · Diabetologia
animal supports moderate [FT-verified] RESOLVED via NCBI PMID IS Phuah 2026 Diabetologia indole->GLP-1+L-cell differentiation diabetic mice; valid support (batch4 mis-IDed). ANIMAL
Meijerink
2021 · Molecules
observational tested-null low Review: fatty-acid/odorant-receptor and serotonin-conjugate signalling shapes L/EC-cell biology - context for Trp-metabolite EEC modulation
Masse
2023 · Front Endocrinol
observational mixed low Review of mechanisms: indoles (with SCFA/bile acids) act as gut-microbial signals stimulating GLP-1 secretion from L cells
Hart J et al] # corrected 2026-08-17 from PubMed; was [(Trp-metabolite organoid)
2025 · (human organoid+rat)
in-vitro supports moderate HUMAN colonic organoids indole+L.acidophilus-TRP augmented EEC differentiation (CHGA); best human-tissue node

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.